Back to DE Deerfield Management Company, L.P.

CPRXCPRX

16 quarters

Position history for DEDeerfield Management Company, L.P.'s holdings in CATALYST PHARMACEUTICALS INC

No. Deerfield Management exited its CPRX (Catalyst Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 3,943,600 shares worth $97.6M. Deerfield Management first reported CPRX in Q3 2022 and held it in 15 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$62.8M

Total Shares Change

-4.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$31.43
0
2026-Q1
Decreased
3.9M
-19.7%
$97.6M1.2%—
0
2025-Q4
Decreased
4.9M
-1.3%
$114.6M1.5%—
0
2025-Q3
Increased
5M
+72.8%
$98M1.5%—
71
2025-Q2
Decreased
2.9M
-15.9%
$62.5M1.1%—
0
2025-Q1
Increased
3.4M
+9.2%
$83M1.6%—
51
2024-Q4
Decreased
3.1M
-49.7%
$65.4M1.2%—
0
2024-Q3
Decreased
6.2M
-31.8%
$123.8M1.9%—
0
2024-Q2
Decreased
9.1M
-0.0%
$141.4M2.4%$15.49
0
2024-Q1
Increased
9.1M
+2.7%
$145.5M2.5%$15.94
53
2023-Q4
Increased
8.9M
+8.5%
$149.4M2.8%$16.81
56
2023-Q3
Unchanged
8.2M
0.0%
$95.8M2.1%$11.69
0
2023-Q2
Decreased
8.2M
-20.9%
$110.1M2.4%—
0
2023-Q1
Increased
10.4M
+76.0%
$171.7M3.8%—
84
2022-Q4
Increased
5.9M
+20.2%
$109.5M2.3%$18.60
61
2022-Q3
New
4.9M
—
$62.8M1.3%—
67

Optional analytics helps us improve. How it’s used